Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Immunology|January 27, 2015
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?Daniel Sanghoon Shin, Antoni Ribas
Frontiers in Cell and Developmental Biology|March 29, 2022
Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic StrategiesKevin Park, Mysore S Veena, Daniel Sanghoon Shin
Journal of Medical Case Reports|April 24, 2021
Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case reportCaroline Y Chen, Charlene M Fares, Daniel Sanghoon Shin
Seminars in Oncology|July 19, 2022
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancerDaniel Sanghoon Shin, Kevin Park, Edward Garon, et al.
American Journal of Physiology. Cell Physiology|April 5, 2013
Role of the fourth transmembrane domain in proton-coupled folate transporter function as assessed by the substituted cysteine accessibility methodDaniel Sanghoon Shin, Rongbao Zhao, Andras Fiser, et al.
American Journal of Physiology. Cell Physiology|July 31, 2012
Functional roles of the A335 and G338 residues of the proton-coupled folate transporter (PCFT-SLC46A1) mutated in hereditary folate malabsorptionDaniel Sanghoon Shin, Rongbao Zhao, Andras Fiser, et al.
American Journal of Physiology. Cell Physiology|July 13, 2012
Identification of a functionally critical GXXG motif and its relationship to the folate binding site of the proton-coupled folate transporter (PCFT-SLC46A1)Rongbao Zhao, Daniel Sanghoon Shin, Andras Fiser, et al.
Pageof 4